Steady increase in revenue will drive up the stock price fairly quickly once all the moving parts settle down. We've had lab buys, lab license deals, R/S, interim ticker, new ticker all in the past 3 months. While I don't want to see expansion stop, because I think in the end that is where the real growth will be, it may be better if things just settled down for a quarter or two so that investors can get some sort of baseline organic growth rate for what is already in place.
News 
Market Data 
Discover 
